Clinical Trials on Malignant Hyperthermia

Total 8 results

  • NCT02964481
    Terminated
    Conditions: Malignant Hyperthermia
  • NCT02561598
    Not yet recruiting
    Conditions: Malignant Hyperthermia
  • NCT04474860
    Recruiting
    Conditions: Malignant Hyperthermia
  • NCT04287556
    Recruiting
    Conditions: Hyperthermia, Malignant
  • NCT01624558
    Withdrawn
    Conditions: Malignant Hyperthermia
  • NCT04610619
    Recruiting
    Conditions: Malignant Hyperthermia, Rhabdomyolysis, RYR1 Variant
  • NCT03964870
    Active, not recruiting
    Conditions: Malignant Hyperthermia, Polymorphisms in Genes RYR1 and CACNAS1S
  • NCT01403402
    Unknown status
    Conditions: Congenital Muscular Dystrophy (Including Unspecified/Undiagnosed), Dystroglycanopathy, Congenital Fiber Type Disproportion, Rigid Spine Muscular Dystrophy, Congenital Myopathy (Including Unspecified/Undiagnosed), Collagen VI CMD (Ullrich CMD, Intermediate, Bethlem Myopathy), Laminin Alpha 2 Related Congenital Muscular Dystrophy, LAMA2-CMD/Merosin Deficient/MDC1A, Walker-Warburg Syndrome, Muscle-Eye-Brain Disease, Fukuyama/Fukutin Related Muscular Dystrophy, Integrin Alpha 7 Deficiency, Integrin Alpha 9 Deficiency, LMNA-CMD/Lamin A/C/Laminopathy, SEPN1-Related Myopathy, Bethlem Myopathy, Actin Aggregation Myopathy, Cap Disease, Central Core Disease, Centronuclear Myopathy, Core Rod Myopathy, Hyaline Body Myopathy, Multiminicore Myopathy, Myotubular Myopathy, Nemaline Myopathy, Tubular Aggregate Myopathy, Zebra Body Myopathy, Reducing Body Myopathy, Spheroid Body Myopathy, LGMD1B (LMNA), LGMD1E (DES), LGMD2G (TCAP), LGMD2H (TRIM32), LGMD2I (FKRP), LGMD2J (TTN), LGMD2K (POMT1), LGMD2M (FKTN), LGMD2N (POMT2), LGMD2O (POMGnT1), LGMD2P (DAG1), LGMD2Q (PLEC1), LGMD2R (DES), LGMD2S (TRAPPC11), LGMD2T (GMPPB), LGMD2U (ISPD), LGMD2V (GAA), Ullrich Congenital Muscular Dystrophy, Titinopathy, Choline Kinase B Receptor, Emery-Dreifuss Muscular Dystrophy, RYR1 Related Myopathy, SYNE1/Nesprin Related Muscular Dystrophy, Telethonin Related Muscular Dystrophy (TCAP/Titin-Cap), Congenital Myasthenic Syndrome, Escobar Syndrome, Myofibrillar Myopathy, Malignant Hyperthermia, Alpha-Dystroglycan Related Muscular Dystrophy (DAG1, DPM1, DPM2, DPM3, FKRP, FKTN), Alpha-Dystroglycan Related Muscular Dystrophy (GAA, ISPD, LARGE, POMT1, POMT2, POMGnT1), Alpha-Dystroglycan Related Muscular Dystrophy (Unspecified/Undiagnosed/Other)